David Shaw is a Senior Director and the Head of Cell Therapy Engineering and Process Development at Genentech, where they oversee the development of cell therapy processes to support the company's portfolio. Currently focused on neo-antigen T cell receptor T cell and stem cell therapies, David has expertise in stable cell line development, lab automation, and recombinant protein expression. Previously, David held roles in molecular biology and protein sciences at Roche Palo Alto and led technical development at Genentech. With over seven years of experience in molecular biology and protein purification, David has also supervised undergraduate and graduate students in academic research settings. David is pursuing a Ph.D. at the University of South Carolina-Columbia and holds a B.Sc. from The University of British Columbia.
This person is not in any teams
This person is not in any offices